Jianpi Yifei decoction for advanced non-small cell lung cancer
Hao Yuan
Abstract
Hao Yuan
Abstract
Objective To explore the effect of Jianpi Yifei decoction for advanced non-small cell lung cancer. Methods The control group was treated with DC chemotherapy; in addition, the observation group was treated with Jianpi Yifei decoction. The clinical efficacies, quality of life, and drug safety in both groups were observed and compared. Results After 2 courses’ treatment, the total effective rate of the observation group was significantly better than that of the control group (54.7% vs. 34.4%, P < 0.05). The improvement rate of KPS was 70.3% in the observation group and was 56.3% in the control group (P < 0.05). The incidence of adverse drug reactions was 14.1% in the observation group and was 32.8% in the control group (P < 0.05). Conclusions Jianpi Yifei decoction for advanced non-small cell lung cancer can improve the curative effect and the quality of life and is highly safe. Key words: Jianpi Yifei decoction; Advanced non-small cell lung cancer; Clinical effect
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effect of Jianpi Yifei decoction for advanced non-small cell lung cancer. Methods The control group was treated with DC chemotherapy; in addition, the observation group was treated with Jianpi Yifei decoction. The clinical efficacies, quality of life, and drug safety in both groups were observed and compared. Results After 2 courses’ treatment, the total effective rate of the observation group was significantly better than that of the control group (54.7% vs. 34.4%, P < 0.05). The improvement rate of KPS was 70.3% in the observation group and was 56.3% in the control group (P < 0.05). The incidence of adverse drug reactions was 14.1% in the observation group and was 32.8% in the control group (P < 0.05). Conclusions Jianpi Yifei decoction for advanced non-small cell lung cancer can improve the curative effect and the quality of life and is highly safe. Key words: Jianpi Yifei decoction; Advanced non-small cell lung cancer; Clinical effect
Key concepts: Decoction, Medicine, Lung cancer, Adverse effect, Internal medicine, Incidence (geometry), Quality of life (healthcare), Cancer